Boehringer Ingelheim GmbH

About Boehringer Ingelheim GmbH

Boehringer Ingelheim GmbH is a global leader in the pharmaceutical industry, dedicated to researching, developing, and manufacturing innovative medicines that improve the health and quality of life for humans and animals alike. Founded in 1885, the company has a rich history of commitment to innovation and excellence.

With a strong focus on research and development, Boehringer Ingelheim invests heavily in discovering new therapies for diseases that have significant unmet medical needs. The company operates in various therapeutic areas, including respiratory diseases, cardiovascular health, oncology, and immunology.

In addition to its human pharmaceuticals division, Boehringer Ingelheim is also a prominent player in the animal health sector, providing vaccines and treatments that enhance the well-being of livestock and pets.

The company’s vision is to create value through innovation, ensuring that their products not only meet the highest standards of quality but also contribute positively to society. Boehringer Ingelheim is committed to sustainability and ethical practices, striving to minimize its environmental impact while maximizing the benefits of its products.

With a workforce of over 50,000 employees worldwide, Boehringer Ingelheim fosters a culture of collaboration and respect, encouraging its team members to contribute their ideas and expertise towards achieving common goals.

Headquartered in Ingelheim am Rhein, Germany, the company has a significant presence in the UK, where it continues to expand its operations and partnerships with local healthcare providers and research institutions.

Through its dedication to scientific advancement and patient care, Boehringer Ingelheim aims to be a trusted partner in health, making a meaningful difference in the lives of people and animals around the globe.